Performance Brokerage Services, the leader in dealership buy-sell activity, announces the Consolidation of Bull Run Harley-Davidson in Manassas, Virginia from Michael C. Lindsay of...
StrataMap Spatial gives researchers access to spatial biology at true single cell resolution for discovery without boundariesWhole-transcriptome profiling across a large tissue capture area...
All the simplicity of Doppler within your own infrastructure.SAN FRANCISCO, June 8, 2026 /PRNewswire/ --
Run Doppler on your termsDoppler announced today the launch of...
Microsoft Azure customers worldwide can now discover and deploy the Ares® Networks Agent Governance Platform through Microsoft Marketplace, accessing trusted solutions that accelerate innovation...
SAN DIEGO, June 8, 2026 /PRNewswire/ -- The Lennox-Gastaut Syndrome (LGS) Foundation today announced the launch of the LGS and Associated DEE Research Accelerator,...
Three new limited-time flavors, limited collectible in-store giveaways, and exclusive digital content launch June 8FARMERS BRANCH, Texas, June 8, 2026 /PRNewswire/ -- Yogurtland, the...
Enhanced Polar Compound Retention and SeparationTORRANCE, Calif., June 8, 2026 /PRNewswire/ -- Phenomenex Inc., a Danaher Company and a global leader in the research...
Enhanced Polar Compound Retention and SeparationTORRANCE, Calif., June 8, 2026 /CNW/ -- Phenomenex Inc., a Danaher Company and a global leader in the research...
Wendy's joins Illumination's Minions & Monsters with a custom menu lineup, exclusive collectibles and a drive-thru takeover in Los AngelesFresh Facts:Get ready to experience...
Enhanced Polar Compound Retention and SeparationTORRANCE, Calif., June 8, 2026 /PRNewswire/ -- Phenomenex Inc., a Danaher Company and a global leader in the research...
SAN MATEO, Calif., June 8, 2026 /PRNewswire/ -- Kali Therapeutics, a clinical-stage biotechnology company pioneering next-generation immune-resetting and multi-specific therapies, today announced that preclinical...
SAN DIEGO, June 8, 2026 /PRNewswire/ -- Sapu Bioscience LLC announced the expansion of its Phase 1b clinical development program for Sapu003 (Everolimus for...
VESALIUS-CV Subgroup Results Show Repatha® Reduces Risk of First Major Cardiovascular Events by 29% in People Living with High-Risk DiabetesNew Real-World Data Highlight Treatment...